Enviro D-T-X
Natural health product licensed in Canada
- Licence holder
- Nature's Sunshine Products of Canada Ltd.
- NPN or DIN-HM
- 80047458
- Status
- Inactive licence
- Licence date
- 9 January 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Frangula purshiana Cooper: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Arctium lappa Source : Racine | 60.2 mg | Not calculated |
| Frangula purshiana Source : Écorce âgée | 18.3 mg | Not calculated |
| Taraxacum officinale Source : Racine | 60.2 mg | Not calculated |
| Silybum marianum Source : Graine(s) Extraction ratio : 35:1 Dry plant equivalent : 21 mg Potency : 80 % Silymarin | 0.6 mg | Not calculated |
| Rumex crispus Source : Racine | 48.2 mg | Not calculated |
| Pepsine A Source : Estomac de Sus Scrofa | 48.2 mg | Not calculated |
| Pepsine A Source : Estomac de Sus Scrofa | 154,240 Unité de pepsine du FCC | Not calculated |
| Zingiber officinale Source : Rhizome | 60.2 mg | Not calculated |
| Althaea officinalis Source : Racine | 24 mg | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 Capsule | 1 day |
Uses authorised in Canada
Contains pepsin, a digestive enzyme. Stimulant laxative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Do not use if you are pregnant or breastfeeding. Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn's disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes or diarrhoea. Do not exceed the recommended dose. Keep away from children. Do not use this product If you have an immune-compromised condition (e.g. AIDS, lymphoma patients undergoing long-term corticosteroid treatment).
- Précautions et mises en garde
If symptoms of digestive upset (e.g. diarrhoea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner. Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea. If you have diabetes, consult a health care practitioner. Consult a health care practitioner prior to use if you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a health care practitioner prior to use if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications. Consult a health care practitioner prior to use if you have faecal impaction or symptoms such as abdominal pain. nausea, vomiting or fever. If you have liver or gall bladder diseases, and/or intestinal obstruction, consult a health care practitioner prior to use. If you are taking Immunosuppressants, consult a health care practitioner prior to use. If you have a progressive systemic disease such as tuberculosis, leukosis, collagenosis or multiple sclerosis, consult a health care practitioner prior to use. If you have gastrointestinal lesions/ulcers, are taking anticoagulant agents or anti-inflammatory agents, or are having surgery, consult a health care practitioner prior to use.
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, In which case, discontinue use.
Source
Official Health Canada record, licence 80047458
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.